Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hetalkumari Patel

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Orthopedics|December 8, 2011
Update on the pharmacological prevention of skeletal-related events in cancer patientsKenneth Kennedy, Hetalkumari Patel
Journal of the Advanced Practitioner in Oncology|August 11, 2025
Imetelstat: A First-in-Class Telomerase Inhibitor for the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes and AnemiaHetalkumari Patel, Selamawit Yohannes, Elissa Brunaugh
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 2, 2026
Creation and application of a value-based framework for formulary managementBrandyn Wilcox, Hetalkumari Patel, Jerry James, et al.
Therapeutic Advances in Hematology|December 30, 2024
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulatorsJulia J Shi, Yusuf M Ozcan, Carlos I Ayala Santos, et al.
Diagnostics (Basel, Switzerland)|April 17, 2020
Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary StudyHana Vakili, Sharon Koorse Germans, Xiuhua Dong, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody TherapiesLenin Mahimainathan, Madhusudhanan Narasimhan, Rolando Corchado, et al.
Journal of Medical Case Reports|April 30, 2021
Combined immune checkpoint blockade and radiotherapy induces durable remission in relapsed natural killer/T-cell lymphoma: a case report and review of the literatureElizabeth McGehee, Hetalkumari Patel, Caroline Pearson, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 6, 2023
Time and personnel costs associated with adverse event (AE) management among patients with chronic lymphocytic leukemia (CLL)Hetalkumari Patel, Svea K Wahlstrom, Maral DerSarkissian, et al.
Transplant Immunology|February 26, 2023
Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experienceFieke W Hoff, Stephen S Chung, Prapti A Patel, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Orthopedics|December 8, 2011
Update on the pharmacological prevention of skeletal-related events in cancer patientsKenneth Kennedy, Hetalkumari Patel
Journal of the Advanced Practitioner in Oncology|August 11, 2025
Imetelstat: A First-in-Class Telomerase Inhibitor for the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes and AnemiaHetalkumari Patel, Selamawit Yohannes, Elissa Brunaugh
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 2, 2026
Creation and application of a value-based framework for formulary managementBrandyn Wilcox, Hetalkumari Patel, Jerry James, et al.
Therapeutic Advances in Hematology|December 30, 2024
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulatorsJulia J Shi, Yusuf M Ozcan, Carlos I Ayala Santos, et al.
Diagnostics (Basel, Switzerland)|April 17, 2020
Complete Depletion of Daratumumab Interference in Serum Samples from Plasma Cell Myeloma Patients Improves the Detection of Endogenous M-Proteins in a Preliminary StudyHana Vakili, Sharon Koorse Germans, Xiuhua Dong, et al.
Diagnostics (Basel, Switzerland)|December 1, 2020
Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody TherapiesLenin Mahimainathan, Madhusudhanan Narasimhan, Rolando Corchado, et al.
Journal of Medical Case Reports|April 30, 2021
Combined immune checkpoint blockade and radiotherapy induces durable remission in relapsed natural killer/T-cell lymphoma: a case report and review of the literatureElizabeth McGehee, Hetalkumari Patel, Caroline Pearson, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 6, 2023
Time and personnel costs associated with adverse event (AE) management among patients with chronic lymphocytic leukemia (CLL)Hetalkumari Patel, Svea K Wahlstrom, Maral DerSarkissian, et al.
Transplant Immunology|February 26, 2023
Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experienceFieke W Hoff, Stephen S Chung, Prapti A Patel, et al.
Pageof 1